Analysis Note
Color (visual): white to slight yellow to beigeAppearance of substance (visual): powderIdentity (IR): passes testEnantiomeric purity: ≥ 99.0 % (a/a)Purity (TLC(011A)): ≥ 98 %Purity (TLC(0811)): ≥ 98 %Assay (HPLC, area%): ≥ 98.0 % (a/a)Solubility (1 mmole in 2 ml DMF): clearly solubleAssay (acidimetric): ≥ 85.0 %Water (K. F.): ≤ 1.50 %For TLC-Systems see our General Catalog
General description
This orthogonally-protected ornithine derivative is based on the hindered Dde variant ivDde. The side-chain ivDde group is considerably more stable to piperidine than Dde and is less prone to migrate from protected to unprotected side-chains [1].
When removing ivDde in the presence of allyl-based protecting groups, allyl alcohol should be included in the deprotection solution to prevent reduction of the allyl group [2].
See references [3, 4] for applications.
The product number for this product was previously 04-12-1203.
To obtain a certificate of analysis (CoA) of a lot that begins with the letter “A”, please select the option in the right hand menu “Request a COA for Lot#s starting with A”.
Legal Information
Novabiochem is a registered trademark of Merck KGaA, Darmstadt, Germany
Linkage
Replaces: 04-12-1203
Packaging
1 g in Glass bottle
This product has met the following criteria to qualify for the following awards: